Heart Transplant

When the Target Is Not the Driver: Rethinking LDL in Cardiac Allograft Vasculopathy Why We Must Rethink Kidney Transplantation as a Cardiovascular Risk–Reducing Intervention in Kidney Failure Predictors of Response to Cardiac Resynchronization Therapy in Pediatric Patients and Patients With Congenital Heart Disease Cell-Free DNA Profiles End-Organ Injury and Predicts Outcomes in Advanced Heart Failure With Left Ventricular Assist Device Implantation Cardiac Allograft Vasculopathy Inhibition With Alirocumab: The CAVIAR Trial Response by Wooster et al to Letter Regarding Article, “Impact of Heart Transplant Allocation Changes on Waitlist Mortality and Clinical Practice in Pediatric and Adult Patients With Congenital Heart Disease and Cardiomyopathy” Letter by Wang et al Regarding Article, “Impact of Heart Transplant Allocation Changes on Waitlist Mortality and Clinical Practice in Pediatric and Adult Patients With Congenital Heart Disease and Cardiomyopathy” Current Status of Donation After Circulatory Determination of Death Heart Transplantation Prolonged Biventricular Berlin Heart EXCOR Support as a Bridge to Heart Transplantation in an Infant: The Victory of Little Warrior Listing for Pediatric Donation After Circulatory Death Heart Transplantation Is Associated With Improved Waitlist Outcomes